special section Advertisement OSOM® C. difficile Toxin A/B Test* OSOM C. difficile Toxin A/B is a rapid test to aid in <strong>the</strong> diagnosis of C. difficile infection. The assay requires just four simple steps, and results are available in 20 minutes or less. No incubation is required, and labs can run <strong>the</strong> test in batch or STAT. An accurate, easy-toread, two-color dipstick provides clear objective results. Each kit contains all <strong>the</strong> materials necessary to run <strong>the</strong> test, plus two additional test sticks <strong>for</strong> external QC. Online training is available anytime at www.osomtraining. com. *Made in <strong>the</strong> U.S. Sekisui Diagnostics, LLC www.sekisuidiagnostics.com Booth No. 2705 Clostridium difficile Immunochromatographic Test* A-B diff is a rapid immunochromatographic test <strong>for</strong> Clostridium difficile detection. Its main innovations compared to o<strong>the</strong>r tests in <strong>the</strong> market are detection of toxin A and toxin B in independent bands. This fact is important <strong>for</strong> making treatment decisions and isolating infected patients. It’s extremely quick, 10 minutes <strong>for</strong> sample preparation plus 15 minutes <strong>for</strong> reading results. It’s a very easy procedure, and it does not require special equipment, merely dissolve <strong>the</strong> stool sample in a buffer and add a quantity of <strong>the</strong> supernatant to <strong>the</strong> strip. HYPER diff is a rapid immunochromatographic test that can detect suspected hypervirulent strains of C. difficile as <strong>the</strong> ribotypes O27 or O17. *Available <strong>for</strong> sale outside <strong>the</strong> U.S. OPERON, S.A. www.operon.es Booth No. 1943 Chagas Disease Detection kits* Wiener Labs has a complete line of kits <strong>for</strong> detection of Chagas disease, a parasitic infection produced by Trypanosoma cruzi. Commonly, <strong>the</strong> disease evolves towards a chronic phase. During <strong>the</strong> acute phase, <strong>the</strong> diagnosis is per<strong>for</strong>med by detection of parasites in blood. During <strong>the</strong> chronic phase, serologic methods are used as screening tests. Today, blood donations in all endemic Latin <strong>American</strong> countries undergo Chagas screening, and 22 CliniCal laboratory news July 2011 2 0 11 N E w P r o d U c T s r E v I E w testing is expanding to o<strong>the</strong>r countries like <strong>the</strong> U.S. The line is composed of: Chagatest ELISA recombinante v.4.0®, Chagatest ELISA recombinante v.3.0®, Chagatest ELISA lisado®, WL Check Chagas®, Chagatest HAI®, Chagatest HAI A-V®. *For research use only. Wiener Laboratories SAIC www.wiener-lab.com.ar Booth No. 3670 iRICELL®pro Automated urinalysis System The iRICELL pro consists of <strong>the</strong> iQ®200 Series Automated Urine Microscopy analyzer and <strong>the</strong> iCHEM®VELOCITY Automated Urine Chemistry analyzer with iWARE® Integrated Urinalysis Software. Iris Diagnostics, a division of IRIS International, Inc. www.irisdiagnostics.com Booth No. 419 BioCode-HP Analyzer* Barcoded Magnetic Beads (BMBs), a digital multiplex plat<strong>for</strong>m, are encoded with a high- contrast pattern that simplifies multiplexed diagnostic and molecular diagnostic assays while offering high throughput, high accuracy, and cost savings. Each bead contains one of 4,096 digital barcodes. Up to 4,096 immunoassay or nucleic acid analytes/ sample can be tested simultaneously in a 96-microwell plate. Biocode-HP Analyzer rapidly scans <strong>the</strong> BMBs, decodes <strong>the</strong> barcode, detects label fluorescence, and displays <strong>the</strong> results. The system provides a wide variety of applications, including infectious diseases, cancer diagnostics, HLA, autoimmune, companion diagnostics, gene expression analysis, micro RNA, genetic testing, and biomarker validation. *For research use only. Applied BioCode, Inc. www.ApBioCode.com Booth No. 2573 MINICAP FLEx Piercing: Whole-Blood Hb Testing* Whole-blood hemoglobinopathy testing by capillary electrophoresis (CE) with cappiercing capabilities is now available with <strong>the</strong> MINICAP FLEX Piercing instrument. The MINICAP FLEX Piercing system with its small footprint is designed to optimize and completely automate electrophoresis testing in low- to medium-volume laboratories. Simply place a barcoded primary tube on <strong>the</strong> system and walk away; <strong>the</strong> whole blood plasma samples are automatically inverted prior to analysis and a continuous access sample wheel allows <strong>for</strong> addition of samples at any time. True positive sample ID is achieved with full traceability. A complete test menu is available, including: protein electrophoresis, immunotyping, and CDT (chronic alcohol abuse marker). *Pending FDA clearance. Available <strong>for</strong> sale outside <strong>the</strong> U.S. Sebia Electrophoresis www.sebia-usa.com Booth No. 3111 CAPILLARYS 2 FLEx Piercing: Whole-Blood Hb Testing* Whole-blood hemoglobinopathy testing by capillary electrophoresis (CE) with cappiercing capabilities is now available with <strong>the</strong> CAPILLARYS 2 FLEX Piercing system. Whole-blood plasma samples are automatically inverted be<strong>for</strong>e sampling to ensure thorough homogenization of <strong>the</strong> sample and accurate Hb results. A high-resolution Hb separation takes place concurrently in eight capillaries with a sample throughput of 37 results per hour. CAPILLARYS 2 FLEX Piercing is a continuous-feed system that provides full traceability from bar-coded primary sample tube to final result. A complete test menu is available, including serum and urine protein electrophoresis; immunotyping; and CDT (chronic alcohol abuse marker). *Pending FDA clearance. Available <strong>for</strong> sale outside <strong>the</strong> U.S. Sebia Electrophoresis www.sebia-usa.com Booth No. 3111 Tumor Marker Control* Fujirebio Diagnostics, Inc., <strong>the</strong> industry leader in biomarker assays, presents its solution <strong>for</strong> accurate precision monitoring of laboratory tumor marker assays. The Tumor Marker Control is intended <strong>for</strong> use as a quantitative, assayed serum control. This is <strong>the</strong> only multi-constituent control to contain <strong>the</strong> novel biomarker HE4 used to monitor progression and recurrence of epi<strong>the</strong>lial ovarian carcinoma. It contains clinically relevant proportions of free PSA and PSA-ACT. Analytes include AFP, CA 15-3, CA 19-9, CA 125, CEA, ferritin, HE4, total PSA, and free PSA. Reconstituted, open-vial stability is 14 days at 2–8ºC with <strong>the</strong> following exception: Free PSA is stable <strong>for</strong> 7 days. The control sustains nine freeze/thaw cycles at ≤–20ºC. *Available <strong>for</strong> sale outside <strong>the</strong> U.S. Fujirebio Diagnostics, Inc. www.fdimcc.com Booth No. 2221 EncompassMDx* Rheonix® introduces an automated microfluidic plat<strong>for</strong>m <strong>for</strong> <strong>the</strong> evolving molecular diagnostics industry. Rheonix CARD® technology automatically processes samples through purification, multiplexed amplification, and endpoint detection, offering true sample-to-result functionality with minimal technician hands-on time. The versatile system can be rapidly customized <strong>for</strong> a broad spectrum of diagnostic applications and incorporates low-cost consumables to analyze raw clinical samples such as blood, saliva, buccal and vaginal swabs. Successful pilot programs have applied a range of functional assays to <strong>the</strong> EncompassMDx plat<strong>for</strong>m, including SNP detection, pathogen identification, immunoassays, cell-based assays, and o<strong>the</strong>r molecular diagnostic applications. *For research use only. Rheonix, Inc. www.rheonix.com Booth No. 4434 Chemiluminescence Immunoassay <strong>for</strong> TB* The Anti-TB kit is a chemiluminescence immunoassay (CLIA) test <strong>for</strong> detecting specific antibodies to Mycobacterium tuberculosis (TB) in human serum or plasma. In conjunction with Chemclin®100, a semi-automated CLIA analyzer, and Chemclin®600, a fully automated CLIA instrument, this assay provides high throughput and reliable detection. This assay offers laboratories higher sensitivity and is more user-friendly than o<strong>the</strong>r ELISA and RIA-based anti-TB assays. *Available <strong>for</strong> sale outside <strong>the</strong> U.S. Beijing Chemclin Biotech Co., Ltd. www.chemclin.com Booth No. 3952 ARCHITECT HIV Ag/Ab Combo Assay* ARCHITECT HIV Ag/Ab Combo assay is a chemiluminescent microparticle immunoassay <strong>for</strong> simultaneous qualitative detection of human immunodeficiency virus (HIV) p24 antigen and antibodies to HIV type 1
See us at <strong>the</strong> 2011 Clin Lab Expo, Booth No. 2611
Change language